Related Experiment Videos
High-throughput screening strategies for cardiac ion channels
1Aurora Biosciences Corporation, 11010 Torreyana Rd., San Diego, CA 92121, USA.
Trends in Cardiovascular Medicine
|September 1, 2001
Summary
New high-throughput screening (HTS) technologies enhance cardiac ion channel drug discovery. Utilizing voltage-sensing Fluorescence Resonance Energy Transfer (FRET) dyes and native cell lines improves screening sensitivity and efficiency.
Area of Science:
- Pharmacology
- Biotechnology
- Cardiovascular Research
Background:
- High-throughput screening (HTS) is crucial for drug discovery.
- Cardiac ion channels are key targets for cardiovascular therapeutics.
- Current HTS methods face challenges in sensitivity and relevance.
Purpose of the Study:
- To review and discuss novel HTS technologies for cardiac ion channels.
- To evaluate the utility of voltage-sensing Fluorescence Resonance Energy Transfer (FRET) dyes.
- To explore the benefits of using "native" cell lines in screening.
Main Methods:
- Review of current cell-based HTS techniques.
- Analysis of gene-centric versus native cell line approaches.
- Assessment of FRET dye technology for ion channel screening.
Main Results:
- Novel HTS technologies offer improved sensitivity and capacity.
- Native cell lines provide a more physiologically relevant screening platform.
- FRET voltage-sensing dyes enhance the detection of ion channel activity.
Conclusions:
- Advanced HTS technologies, particularly with FRET dyes and native cells, are vital for efficient cardiac ion channel drug discovery.
- Screening against multiple targets in endogenous cardiac cell lines presents a promising strategy.